165 related articles for article (PubMed ID: 32330901)
1. The expression of PDGF-BB predicts curative effect in locally advanced esophageal squamous cell carcinoma treated by radiotherapy.
Er P; Qian D; Zhang W; Zhang B; Wei H; Zhang T; Chen X; Wang Y; Zhao J; Wang Q; Pang Q; Wang P
Aging (Albany NY); 2020 Apr; 12(8):6586-6599. PubMed ID: 32330901
[TBL] [Abstract][Full Text] [Related]
2. CircVRK1 regulates tumor progression and radioresistance in esophageal squamous cell carcinoma by regulating miR-624-3p/PTEN/PI3K/AKT signaling pathway.
He Y; Mingyan E; Wang C; Liu G; Shi M; Liu S
Int J Biol Macromol; 2019 Mar; 125():116-123. PubMed ID: 30508543
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma
Hu DX; Sun QF; Xu L; Lu HD; Zhang F; Li ZM; Zhang MY
World J Gastroenterol; 2022 Jan; 28(4):464-478. PubMed ID: 35125830
[TBL] [Abstract][Full Text] [Related]
4. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway.
Zhang Y; Chen W; Wang H; Pan T; Zhang Y; Li C
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1209-1218. PubMed ID: 31529206
[TBL] [Abstract][Full Text] [Related]
6. lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET.
Wang P; Yang Z; Ye T; Shao F; Li J; Sun N; He J
J Exp Clin Cancer Res; 2020 Jan; 39(1):7. PubMed ID: 31918742
[TBL] [Abstract][Full Text] [Related]
7. The ATPase subunit of ATP6V1C1 inhibits autophagy and enhances radiotherapy resistance in esophageal squamous cell carcinoma.
Yao X; Chen H; Xu B; Lu J; Gu J; Chen F; Ju M; Sun X
Gene; 2021 Feb; 768():145261. PubMed ID: 33183740
[TBL] [Abstract][Full Text] [Related]
8. Targeting valosin-containing protein enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma.
Luo H; Song H; Mao R; Gao Q; Feng Z; Wang N; Song S; Jiao R; Ni P; Ge H
Cancer Sci; 2019 Nov; 110(11):3464-3475. PubMed ID: 31454136
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
[TBL] [Abstract][Full Text] [Related]
10. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA (lncRNA) Growth Arrest Specific 5 (GAS5) Suppresses Esophageal Squamous Cell Carcinoma Cell Proliferation and Migration by Inactivating Phosphatidylinositol 3-kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
Wang G; Sun J; Zhao H; Li H
Med Sci Monit; 2018 Oct; 24():7689-7696. PubMed ID: 30368517
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
13. Lobaplatin promotes radiosensitivity, induces apoptosis, attenuates cancer stemness and inhibits proliferation through PI3K/AKT pathway in esophageal squamous cell carcinoma.
Pan S; Sun Y; Sui D; Yang T; Fu S; Wang J; Hui B; Xi R; He C; Zhang X
Biomed Pharmacother; 2018 Jun; 102():567-574. PubMed ID: 29597090
[TBL] [Abstract][Full Text] [Related]
14. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.
Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL
Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358
[TBL] [Abstract][Full Text] [Related]
15. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
16. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.
He SL; Wang WP; Yang YS; Li EM; Xu LY; Chen LQ
J Cell Mol Med; 2019 Feb; 23(2):1375-1385. PubMed ID: 30565387
[TBL] [Abstract][Full Text] [Related]
17. circGSK3β promotes metastasis in esophageal squamous cell carcinoma by augmenting β-catenin signaling.
Hu X; Wu D; He X; Zhao H; He Z; Lin J; Wang K; Wang W; Pan Z; Lin H; Wang M
Mol Cancer; 2019 Nov; 18(1):160. PubMed ID: 31722716
[TBL] [Abstract][Full Text] [Related]
18. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis.
Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F
Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939
[TBL] [Abstract][Full Text] [Related]
19. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of microRNA-136 induces apoptosis and radiosensitivity of esophageal squamous cell carcinoma cells by inhibiting the expression of MUC1.
Huang HZ; Yin YF; Wan WJ; Xia D; Wang R; Shen XM
Exp Mol Pathol; 2019 Oct; 110():104278. PubMed ID: 31247211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
